HIGH-GRADE OSTEOSARCOMA
Clinical trials for HIGH-GRADE OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for HIGH-GRADE OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to boost survival for young bone cancer patients
Disease control Recruiting nowThis large study is testing if adding a newer drug called cabozantinib to standard chemotherapy works better for treating newly diagnosed osteosarcoma, a type of bone cancer. It will involve over 1,100 patients under 40 years old, comparing the new combination against standard ch…
Matched conditions: HIGH-GRADE OSTEOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Simple blood test could predict deadly bone Cancer's return
Knowledge-focused Recruiting nowThis study is testing whether a blood test can predict if two types of bone cancer (Ewing sarcoma and osteosarcoma) will come back after treatment. Researchers will collect blood samples from about 340 patients aged 1 to 50 years old to look for tiny pieces of tumor DNA. The goal…
Matched conditions: HIGH-GRADE OSTEOSARCOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC